{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:58:42Z","timestamp":1791932322456,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ebiom.2019.09.055","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T19:00:40Z","timestamp":1571338840000},"page":"223-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-9587","authenticated-orcid":false,"given":"Andrea","family":"Marzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierce","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo","family":"Mercado-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Callison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Rosenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana P.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Haddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2019.09.055_bib0001","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of Ebola virus disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0002","unstructured":"WHO. Ebola situation report, 30 March 20162016. http:\/\/apps.who.int\/ebola\/current-situation\/ebola-situation-report-30-march-2016(accessed)."},{"issue":"15","key":"10.1016\/j.ebiom.2019.09.055_bib0003","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMoa1404505","article-title":"Emergence of Zaire Ebola virus disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"New Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2019.09.055_bib0004","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrd.2017.251","article-title":"Post-exposure treatments for Ebola and Marburg virus infections","volume":"17","author":"Cross","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.ebiom.2019.09.055_bib0005","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1080\/14760584.2016.1178068","article-title":"Ebola virus vaccines - reality or fiction?","volume":"15","author":"Mire","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0006","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-pharmtox-010716-105055","article-title":"Will there be a cure for Ebola?","volume":"57","author":"Cardile","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.09.055_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40259-018-0329-7","article-title":"Current Ebola virus vaccine progress","volume":"33","author":"Marzi","year":"2019","journal-title":"BioDrugs"},{"issue":"7","key":"10.1016\/j.ebiom.2019.09.055_bib0008","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"issue":"6249","key":"10.1016\/j.ebiom.2019.09.055_bib0009","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"Marzi","year":"2015","journal-title":"Science"},{"issue":"9996","key":"10.1016\/j.ebiom.2019.09.055_bib0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"10068","key":"10.1016\/j.ebiom.2019.09.055_bib0011","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0012","article-title":"WHO's Tedros: experimental Ebola vaccine in the DRC has saved countless lives","author":"Branswell","year":"2019","journal-title":"Stat"},{"issue":"5","key":"10.1016\/j.ebiom.2019.09.055_bib0013","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1073\/pnas.1209591110","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ebiom.2019.09.055_bib0014","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine - Preliminary Report","volume":"376","author":"Regules","year":"2017","journal-title":"New Eng J Med"},{"issue":"7","key":"10.1016\/j.ebiom.2019.09.055_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1473-3099(18)30165-8","article-title":"Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study","volume":"18","author":"Huttner","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2019.09.055_bib0016","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2019.09.055_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002402","article-title":"Safety and immunogenicity of rVSVDeltaG-ZEBOV-GP Ebola vaccine in adults and children in Lambarene, Gabon: a phase I randomised trial","volume":"14","author":"Agnandji","year":"2017","journal-title":"PLoS Med"},{"issue":"24","key":"10.1016\/j.ebiom.2019.09.055_bib0018","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1503\/cmaj.170074","article-title":"Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial","volume":"189","author":"ElSherif","year":"2017","journal-title":"CMAJ"},{"issue":"8","key":"10.1016\/j.ebiom.2019.09.055_bib0019","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S1473-3099(17)30313-4","article-title":"Safety and immunogenicity of the rVSVG-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study","volume":"17","author":"Heppner","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0020","unstructured":"soch h. WHO adapts Ebola vaccination strategy in the Democratic Republic of the Congo to account for insecurity and community feedback. 2019. https:\/\/www.healthysoch.com\/health\/general\/who-adapts-ebola-vaccination\/."},{"issue":"12","key":"10.1016\/j.ebiom.2019.09.055_bib0021","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/infdis\/jix189","article-title":"Six-Month safety data of recombinant vesicular stomatitis virus-zaire Ebola virus envelope glycoprotein vaccine in a phase 3 double-blind, placebo-controlled randomized study in healthy adults","volume":"215","author":"Halperin","year":"2017","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.ebiom.2019.09.055_bib0022","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe - Preliminary Report","volume":"374","author":"Agnandji","year":"2016","journal-title":"New Eng J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2019.09.055_bib0023","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/jvi.70.4.2318-2323.1996","article-title":"The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus","volume":"70","author":"Schnell","year":"1996","journal-title":"J Virol"},{"issue":"Suppl 3","key":"10.1016\/j.ebiom.2019.09.055_bib0024","doi-asserted-by":"crossref","first-page":"S1066","DOI":"10.1093\/infdis\/jir348","article-title":"Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy","volume":"204","author":"Marzi","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0025","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.3389\/fimmu.2018.03071","article-title":"Protection against Marburg virus using a recombinant VSV-Vaccine depends on T and B cell activation","volume":"9","author":"Marzi","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2019.09.055_bib0026","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3201\/eid2110.150259","article-title":"Delayed disease progression in cynomolgus macaques infected with Ebola virus Makona strain","volume":"21","author":"Marzi","year":"2015","journal-title":"Emerging Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2019.09.055_bib0027","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"5","key":"10.1016\/j.ebiom.2019.09.055_bib0028","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4269\/ajtmh.18-0937","article-title":"Gamma irradiation as an effective method for inactivation of emerging viral pathogens","volume":"100","author":"Feldmann","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ebiom.2019.09.055_bib0029","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4269\/ajtmh.19-0076","article-title":"Effect of gamma irradiation on the antibody response measured in human serum from subjects vaccinated with recombinant vesicular stomatitis virus-zaire Ebola virus envelope glycoprotein vaccine","volume":"101","author":"Grant-Klein","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.ebiom.2019.09.055_bib0030","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1038\/s41598-018-29401-x","article-title":"A VSV-based Zika virus vaccine protects mice from lethal challenge","volume":"8","author":"Emanuel","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ebiom.2019.09.055_bib0031","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"issue":"Suppl 2","key":"10.1016\/j.ebiom.2019.09.055_bib0032","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1093\/infdis\/jiv188","article-title":"Stat1-Deficient mice are not an appropriate model for efficacy testing of recombinant vesicular stomatitis virus-based filovirus vaccines","volume":"212","author":"Marzi","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2019.09.055_bib0033","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/s41598-017-01032-8","article-title":"Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection","volume":"7","author":"Menicucci","year":"2017","journal-title":"Sci Rep"},{"issue":"suppl 3","key":"10.1016\/j.ebiom.2019.09.055_bib0034","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1093\/infdis\/jiw149","article-title":"Oral and conjunctival exposure of nonhuman primates to low doses of Ebola Makona virus","volume":"214","author":"Mire","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"suppl 3","key":"10.1016\/j.ebiom.2019.09.055_bib0035","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.1093\/infdis\/jiw267","article-title":"Pathogenicity comparison between the Kikwit and Makona Ebola virus variants in rhesus macaques","volume":"214","author":"Wong","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2018.1473698","article-title":"The vesicular stomatitis virus-based Ebola virus vaccine: from concept to clinical trials","author":"Suder","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.ebiom.2019.09.055_bib0037","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/vim.2014.0069","article-title":"VSVDeltaG\/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection","volume":"28","author":"Williams","year":"2015","journal-title":"Viral Immunol"},{"issue":"7201","key":"10.1016\/j.ebiom.2019.09.055_bib0038","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"issue":"Suppl 3","key":"10.1016\/j.ebiom.2019.09.055_bib0039","doi-asserted-by":"crossref","first-page":"S825","DOI":"10.1093\/infdis\/jir295","article-title":"Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles","volume":"204","author":"Martinez","year":"2011","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2019.09.055_bib0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1473-3099(19)30124-0","article-title":"2018 Ebola virus disease outbreak in Equateur province, democratic republic of the Congo: a retrospective genomic characterisation","volume":"19","author":"Mbala-Kingebeni","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"20","key":"10.1016\/j.ebiom.2019.09.055_bib0041","doi-asserted-by":"crossref","DOI":"10.1128\/MRA.00360-19","article-title":"Complete genome sequence of a new Ebola virus strain isolated during the 2017 likati outbreak in the democratic Republic of the Congo","volume":"8","author":"Wawina-Bokalanga","year":"2019","journal-title":"Microbiol Resour Announc"},{"issue":"14","key":"10.1016\/j.ebiom.2019.09.055_bib0042","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of Ebola virus","volume":"83","author":"Geisbert","year":"2009","journal-title":"J Virol"},{"issue":"Suppl 2","key":"10.1016\/j.ebiom.2019.09.055_bib0043","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1086\/520591","article-title":"Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever","volume":"196","author":"Jones","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0044","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ebiom.2017.03.045","article-title":"Dose-dependent T-cell dynamics and cytokine cascade following rVSV-ZEBOV immunization","volume":"19","author":"Dahlke","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0045","doi-asserted-by":"crossref","first-page":"27944","DOI":"10.1038\/srep27944","article-title":"Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine","volume":"6","author":"Farooq","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0046","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2019.1649532","article-title":"Recombinant vesicular stomatitis virus vector vaccines for who blueprint priority pathogens","author":"Fathi","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ebiom.2019.09.055_bib0047","article-title":"WHO, preparing for the worst, makes plans for reduced doses of Ebola vaccine","author":"Branswell","year":"2019","journal-title":"Stat"},{"issue":"12","key":"10.1016\/j.ebiom.2019.09.055_bib0048","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S1473-3099(17)30541-8","article-title":"Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report","volume":"17","author":"Gsell","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"15","key":"10.1016\/j.ebiom.2019.09.055_bib0049","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia","volume":"377","author":"Kennedy","year":"2017","journal-title":"New Eng J Med"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419306516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419306516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:56:45Z","timestamp":1762455405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419306516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":49,"alternative-id":["S2352396419306516"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.055","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}